Cancer is a Metabolic Disease, Not Just Genetic
Insights from the The Diary Of A CEO episode “Cancer Scientist: This Common Daily Diet May Be Feeding Cancer! - Thomas Seyfried”, published July 16, 2026.
In "Cancer Scientist: This Common Daily Diet May Be Feeding Cancer! - Thomas Seyfried" (The Diary Of A CEO, July 2026), professor Thomas Seyfried argues that cancer originates from damaged mitochondria, forcing cells to rely on ancient fermentation pathways fueled by glucose and glutamine. By shifting the body into a state of nutritional ketosis, patients can starve tumor cells while protecting healthy tissue, significantly enhancing the…
In "Cancer Scientist: This Common Daily Diet May Be Feeding Cancer! - Thomas Seyfried" (The Diary Of A CEO, July 2026), the intended audience is: Cancer patients, caregivers, and individuals interested in metabolic health and chronic disease prevention.
Professor Thomas Seyfried argues that cancer originates from damaged mitochondria, forcing cells to rely on ancient fermentation pathways fueled by glucose and glutamine. By shifting the body into a state of nutritional ketosis, patients can starve tumor cells while protecting healthy tissue, significantly enhancing the efficacy of conventional treatments.
Cancer patients, caregivers, and individuals interested in metabolic health and chronic disease prevention.
Topics: cancer, mitochondria, metabolic-therapy, ketosis, oncology
Yedapo reads podcasts and YouTube for you. Summaries, key takeaways and Ask AI for thousands of episodes.
Professor Thomas Seyfried argues that cancer originates from damaged mitochondria, forcing cells to rely on ancient fermentation pathways fueled by glucose and glutamine. By shifting the body into a state of nutritional ketosis, patients can starve tumor cells while protecting healthy tissue, significantly enhancing the efficacy of conventional treatments.
Sign up free to unlock the full analysis, chapters, key concepts, and Ask AI.
Save this summary
Export to Markdown, Obsidian, or Notion — a Pro feature.